Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based ingredients, announced a strategic investment with Beren Therapeutics and the launch of an innovation agreement to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications. 
These collaborations among key players are vital to advance cyclodextrin-based innovations and to bring bright ideas closed to the market.
Way to go, guys!

Original press release here!